Novel linear-amphipathic cationic antimicrobial peptides via disulfide-stabilized design show potent, lower-toxicity activity against resistant pathogens.
Hydrogen-peroxide-activated nucleotide prodrugs release active nucleotides in oxidative-stress tissues, enabling targeted cancer and antiviral therapies.
